Skip to main content
. 2019 Aug 28;178(3):657–663. doi: 10.1007/s10549-019-05415-5

Fig. 1.

Fig. 1

Loss of heterozygosity (LOH) analysis in breast cancer tissues from eight carriers of XRCC2 c.96delT mutation; the c.96delT variant is indicated by arrow (↓)